Position in SVTR
Snapshot 2026-11-05- Investor SignalsRankedof 2,691↓53
- Life SciencesFactual rankingTop 25%↓4
5 confirmed deals in 24 months
🔒 Sign in for the exact rank and neighbours★ SVTR RatingSVTR has evaluated this company
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
AI investments
Deals by year
By round
By sector
By region
5 companies · 6 deals
| NanoCoreChip | Series C | $139M | 2026-10 |
| Deep Pharma | Series D+ | $40M | 2026-03 |
| PaXini | Series B | $139M | 2026-03 |